Abbisko Medicine Co., Ltd. (HKG:2256)
Hong Kong · Delayed Price · Currency is HKD 6.33
+0.03 (0.40%)
Nov 10, 2026, 4:08 PM HKT
Abbisko Medicine Market Cap
Abbisko Medicine has a market cap or net worth of 4.19 billion as of November 9, 2026. It is the 14,038th most valuable company in the world and the 644th biggest in Hong Kong. Its market cap has decreased by 56.00% in one year.
Market Cap
4.19B
Enterprise Value
1.87B
Revenue
112.29M
Global Rank
Country Rank
#644 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since October 15, 2021, Abbisko Medicine's market cap has decreased from 8.71B to 4.19B, a decrease of -51.90%. That is a compound annual growth rate of -13.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 4.19B | -52.11% |
| Dec 31, 2025 | 8.75B | 204.13% |
| Dec 31, 2024 | 2.88B | 21.63% |
| Dec 29, 2023 | 2.36B | 4.97% |
| Dec 30, 2022 | 2.25B | -64.77% |
| Dec 31, 2021 | 6.39B | -26.60% |
| Oct 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lepu Biopharma | 5.20B |
| CK Life Sciences Int'l., (Holdings) | 5.05B |
| Ascletis Pharma | 4.81B |
| LongBio Pharma (Suzhou) | 4.35B |
| Ocumension Therapeutics | 4.12B |
| Hanx Biopharmaceuticals (Wuhan) | 3.68B |
| Mirxes Holding Company | 3.66B |
| Jacobio Pharmaceuticals Group | 3.65B |